Weaning Approaches for Vasopressin in Sepsis
Key facts
- Who runs it
- Hospital Nossa Senhora da Conceicao
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 82 people, planned
- Started
- 1 Oct 2025
- Expected to end
- 1 Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Titrated weaning of vasopressin.
- Abrupt weaning of vasopressin.
- Record updated
- 2 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Age over 18 years
- Admitted to the Intensive Care Unit
- Patients with vasopressor dependent sepsis
- Receiving combined norepinephrine and vasopressin therapy
Who cannot take part
- Withdrawal/reduction of vasopressin related to a plan of treatment limitation or palliative care
- Withdrawal/reduction of vasopressin associated with the initiation of adrenaline or any other vasopressor
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Septic shock
This trial is currently available in Brazil.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this study, we aim to evaluate the incidence of hypotension during vasopressin weaning by comparing two methods - titrated reduction versus abrupt withdrawal - through the conduct of a randomized clinical trial.
The 2 groups in the trial
- Titrated groupTreatment being tested
The titrated group will follow the vasopressin weaning protocol used in the DOVSS study (reduction of 0.01 U/min per hour).
Treatment: Titrated weaning of vasopressin.
- Abrupt groupExisting treatment, for comparison
The abrupt group will discontinue the vasopressin infusion at the time of randomization, without dose titration.
Treatment: Abrupt weaning of vasopressin.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Weaning Approaches for Vasopressin in Sepsis - a Randomized Controlled Trial of Titrated Versus Abrupt Discontinuation During Stabilization of Septic Shock - WAVES Trial
- Criteria questions
- Built from NCT07067866, who can take part
- Record updated
- 2 January 2026